3653 results for «414»
3653 results
Transcatheter mitral valve implantation
22 Nov 2021 – From PCR London Valves 2021
Shot in the simulation lab at the PCR London Valves 2021 Congress, this session enables you to see some of the anatomical specimens and devices currently used for transcatheter mitral valve replacement and witness a Tendyne implantation from start to finish using a simulated heart.
Transcatheter mitral edge-to-edge repair: procedural complications and lifetime management
23 Nov 2021 – From PCR London Valves 2021
This PCR London Valves 2021 session presents different kinds of complications in mitral procedures based on clinical cases: discuss the case of an 82-year-old male patient with symptomatic severe ischemic secondary mitral regurgitation, coronary artery disease, diabetes, and chronic kidney disease, among others!
Transcatheter tricuspid valve interventions: the future
23 Nov 2021 – From PCR London Valves 2021
In this PCR London Valves 2021 session, observe the case of an 84-year-old, not overweight, quite active, female patient with a past history of restrictive cardiomyopathy and permanent atrial fibrillation, who presented with worsening dyspnea and obvious clinical signs of right ventricular heart failure, and discuss the...
Coronary access following TAVI
23 Nov 2021 – From PCR London Valves 2021
Using the anatomy and imaging section and simulators, our experts dissect the case of a typical TAVI patient, an 81-year-old male, former smoker, with hypertension, dyslipidemia, and gastric ulcer, symptomatic of effort dyspnea, with marked left ventricular hypertrophy and all the parameters of severe aortic stenosis,...
Tricuspid valve disease: guidelines and beyond
23 Nov 2021 – From PCR London Valves 2021
Watch this PCR London Valves 2021 session to hear about the latest European guidelines on the management of tricuspid valve disease, understand the details behind these guidelines and how they compare with those elsewhere in the world, and, most importantly, find out how Heart Teams can translate...
Transcatheter mitral valve repair and replacement: optimal technique and procedural refinement
23 Nov 2021 – From PCR London Valves 2021
This PCR London Valves 2021 interactive learning session is designed to review the basics but also the more advanced and complex procedural steps of transcatheter mitral edge-to-edge repair, as this procedure requires a rigorous and standardized technique that can take time to learn.
Commissural alignment for TAVI
23 Nov 2021 – From PCR London Valves 2021
In this PCR London Valves 2021 session shot in the simulation lab, learn tips and tricks for achieving commissural alignment, review the strategy for improving TAVR outcomes, and discuss how to get the right imaging, the right tools, and the right patients.
Closing Ceremony
23 Nov 2021 – From PCR London Valves 2021
Looking back on some of the key moments of the PCR London Valves 2021, it is clear that we witnessed cutting-edge procedures in all three valves, pushed the guidelines to the limits and beyond, saw the future of valve procedures with a new TAVI device implanted, live-implanted...
Four-Year Outcomes from the EVOLUT Low Risk Trial
26 Oct 2023
Dejan Milasinovic provides his take on the EVOLUT Low Risk trial, presented by Michael I. Reardon at TCT Congress 2023. 4-year results reveal a continuing trend towards lower combined rates of all-cause mortality and disabling stroke with TAVI compared with surgical aortic valve replacement (SAVR)
Author
Innvolution Healthcare reports one-year findings from the ALCHEMY study evaluating Eternia in 1000 patients at EuroPCR 2026
27 May 2026
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial
01 Apr 2025
Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.
Author
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.
Author
